USTEKINUMAB
ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
USTEKINUMAB (14933Y)
14933Y
Manner of administration:Injection
Restriction (Streamlined authority code: 16886)
Indication: Severe chronic plaque psoriasis
Treatment phase: Subsequent continuing treatment (Whole body)
Restriction (Streamlined authority code: 16911)
Indication: Severe chronic plaque psoriasis
Treatment phase: Subsequent continuing treatment (Face, hand, foot)
